Group One Trading’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,607
Closed -$27K 5695
2014
Q4
$27K Sell
1,607
-395,518
-100% -$5.56M ﹤0.01% 3799
2014
Q3
$4.73M Buy
+397,125
New +$2.71M 0.07% 315
2014
Q2
Sell
-350,066
Closed -$1.61M 5849
2014
Q1
$1.28M Sell
350,066
-131,776
-27% -$502K 0.02% 902
2013
Q4
$1.62M Buy
481,842
+293,245
+155% +$1.21M 0.02% 766
2013
Q3
$800K Buy
188,597
+117,407
+165% +$556K 0.02% 1186
2013
Q2
$327K Buy
+71,190
New +$245K 0.01% 1713

Group One Trading's AVNR Position: Q1 2015 in Review

Group One Trading sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,607 shares — an estimated $27K sold.

Group One Trading first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $4.73M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Group One Trading reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Group One Trading sold 1,607 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $27K.
  • Group One Trading first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
  • Group One Trading's AVANIR PHARMACEUTICALS, INC CL A position peaked at $4.73M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Group One Trading's 13F filing for Q1 2015, filed 14 May 2015.